Clarithromycin Tablet, Film Coated
Product Images NDC 62332-345

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 62332-345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clarithromycin-250-mg.jpg (Clarithromycin 250 mg)

Clarithromycin-250-mg.jpg (Clarithromycin 250 mg)
This is a label for a bottle of Clarithromycin tablets, USP, each containing 250mg of the medication. It is advised not to accept the bottle if the seal over the bottle opening is broken or missing. The tablets should be dispensed in a light-resistant container. The medication is manufactured by Alombic Pharmaceuticals Limited in Gujarat, India, and is distributed by Alombic Pharmaceuticals, Inc. in Bedminster, NJ. The usual adult dose is one or two tablets every twelve hours, and the package insert should be consulted for full prescribing information. The label includes an NDC number and a GTIN code for tracking purposes.*
FDA Label Image

Clarithromycin-500-mg.jpg (Clarithromycin 500 mg)

Clarithromycin-500-mg.jpg (Clarithromycin 500 mg)
This is a description of a medication. The tablet contains 500mg of Clarithromycin and is labeled with NDC number 62332-345-30. It is a USP high-temperature-resistant tablet and must be stored at 15°-30°C (59°-86°F). The tablet is dispensed with a prescription, and the manufacturer is Alembic Pharmaceuticals located in Gujarat, India. The text also includes information on the size and quantity of the tablets.*
FDA Label Image

Figure 2 (Clarithromycin Figure2)

Figure 2 (Clarithromycin Figure2)
This is a chart comparing the mean plasma concentration (mcg/mL) of Clarithromycin Extended-Release tablets (2 x 500 mg q24h) and Clarithromycin tablets (500 mg q12h) over a 24-hour period. The x-axis shows time after dosing in hours.*
FDA Label Image

Figure 3 (Clarithromycin Figure3)

FDA Label Image

Structure (Clarithromycin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.